Welcome to the AGA Self-Assessment Module (SAM) on obesity. Originally authored in 2015, the content was reviewed in April 2020 and updated to match current scientific knowledge.
We’re excited to re-offer this very popular learning module for your use in studying and staying current. We believe SAMs represents a unique contribution to your continuing medical education.
Given the impact of the obesity epidemic and its complications on the American health scene, gastroenterologists are likely to find themselves increasingly engaged in contributing to the management of these patients. This module should serve all learners as a useful exercise for identifying any current knowledge gaps, and providing the resources for self-directed learning. The module questions were written in a boards-style format, with a high level of review for content and function and meet the ABIM standards to provide 5 MOC credits in medical knowledge toward the ABIM requirements in the Maintenance of Certification pathway. The module questions also serve to provide excellent practice for your board exam review in a focused, niche area of gastroenterology and internal medicine.
Sign in to access [Member Only]
After you sign in, please click the "Launch" button on the top of this page to access the course.
Learning objectives
- Recognize the health hazards of obesity; specifically the increased risk of certain cancers, infertility and cholelithiasis.
- Identify obesity as a risk factor for the development of esophageal adenocarcinoma.
- Correctly identify serum lab values consistent with a vomiting disorder.
- Recognize lorcaserin as a serotonin agonist that decreases appetite.
- Recognize the signs and symptoms of night eating syndrome.
- Describe contraindications for phentermine-topiramate use in obese patients.
- Recognize diarrhea and cramping as common side effects of orlistat.
Faculty
Editors:
Arthur J. DeCross, MD, AGAF
Amy S. Oxentenko, MD, AGAF, FACP, FACG
Authors:
Danielle E. Marino, MD
Melissa G. Teitelman, MD
Daniel M. Wild, MD
Pricing
|
Member
|
Nonmember
|
$Free
|
Not available to nonmembers
(member only) |
Accreditation and designation
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AGA Institute designates this enduring material activity for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC statement
Successful completion of this activity, which includes participation in the evaluation component, enables the participant to earn up to 5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
MOC/CME expiration date: April 30, 2021
The following disclosures were presented by faculty and staff at the time this SAM was authored.
Arthur J. DeCross, MD, AGAF
Disclosed no relevant financial relationships
Christine Granato, MD
Disclosed no relevant financial relationships
Millie D. Long, MD, MPH
Consultant: Abbvie, Salix
Advisory Board: Abbvie
Grant/Research Support: Glaxo Smith Kline
Danielle E. Marino, MD
Disclosed no relevant financial relationships
Amy S. Oxentenko, MD, AGAF, FACP, FACG
Disclosed no relevant financial relationships
Melissa G. Teitelman, MD
Disclosed no relevant financial relationships
Daniel M. Wild, MD
Disclosed no relevant financial relationships
Planning Committee
Arthur J. DeCross, MD, AGAF
Disclosed no relevant financial relationships
Jane E. Onken, MD, MHS, AGAF
Member: BMS DMC
Major Stock Shareholder: Merck
Suzanne Rose, MD, MSEd, AGAF
Major Stock Shareholder: Abbott Labs, Baxter International, Johnson & Johnson, Novo Nordisk, Perrigo
Advisory Committees or Review Panels: AAMC
AGA Staff
Maura H. Davis
Disclosed no relevant financial relationships
